Companies Dominating the Blood Glucose Monitoring Devices Landscape
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Ascensia Diabetes Care Holdings AG
- Dexcom, Inc.
- NIPRO CORPORATION
- Prodigy Diabetes Care, LLC
- ACON Laboratories, Inc.
- Insulet Corporation
- Ypsomed AG
- Terumo Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Blood Glucose Monitoring Devices Market in 2025 is evaluated at USD 20.85 billion.
The global market size crossed USD 19.31 billion in 2024 and is likely to register a CAGR of over 10%, exceeding USD 66.66 billion revenue by 2037.
North America is expected to approach largest share by 2037, attributed to rising cases of diabetes and increasing adoption of advanced blood glucose monitoring devices.
The major players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
